Tom Malinowski 🔔 get alerts
US Congress (House) · disclosed stock trades and performance vs S&P 500 (2019-2026)
18 %
of picks beat the S&P
-36.4 %
median 12m outperf.
55
buys analyzed
YEXT, PCRX, CDNA
top holdings
In short — Tom Malinowski underperforms the market: of 55 buys, 18% beat the S&P 500 over 12 months (median outperformance -36.4 %).
Tom Malinowski's disclosed trades
| Disclosed i ▼ | Stock i ↕ | Amount i ↕ | Perf vs S&P (12m) i ↕ |
|---|---|---|---|
| Aug 26, 21 | AMRC | $1k | +6.6 % |
| Aug 26, 21 | AMRC | $1k | +6.6 % |
| Aug 26, 21 | AMRC | $1k | +6.6 % |
| Aug 26, 21 | AMRC | $15k | +6.6 % |
| Aug 26, 21 | ANIK | $1k | -36.4 % |
| Aug 26, 21 | ANIK | $1k | -36.4 % |
| Aug 26, 21 | ANIK | $50k | -36.4 % |
| Aug 26, 21 | CDNA | $1k | -65.2 % |
| Aug 26, 21 | CDNA | $1k | -65.2 % |
| Aug 26, 21 | CDNA | $1k | -65.2 % |
| Aug 26, 21 | CDNA | $1k | -65.2 % |
| Aug 26, 21 | DOMO | $15k | -67.5 % |
| Aug 26, 21 | DOMO | $15k | -67.5 % |
| Aug 26, 21 | DASH | $15k | -58.5 % |
| Aug 26, 21 | MAC | $1k | -30.0 % |
| Aug 26, 21 | YEXT | $15k | -57.5 % |
| Aug 26, 21 | YEXT | $1k | -57.5 % |
| Aug 26, 21 | YEXT | $1k | -57.5 % |
| Aug 26, 21 | YEXT | $1k | -57.5 % |
| Jul 9, 21 | EQIX | $1k | -11.4 % |
| Jul 9, 21 | EQIX | $1k | -11.4 % |
| Jul 9, 21 | EQIX | $1k | -11.4 % |
| Jul 9, 21 | POST | $15k | +28.6 % |
| Jun 23, 21 | PCRX | $1k | +0.1 % |
| Jun 12, 21 | PCRX | $1k | -3.0 % |
| Jun 12, 21 | PTON | $15k | -80.2 % |
| Jun 12, 21 | TDC | $50k | -12.2 % |
| Apr 10, 21 | AI | $15k | -75.1 % |
| Apr 10, 21 | CDNA | $15k | -59.5 % |
| Mar 6, 21 | TDC | $15k | -6.9 % |
| Mar 5, 21 | ANIK | $1k | -15.3 % |
| Mar 5, 21 | ANIK | $15k | -15.3 % |
| Mar 5, 21 | CDNA | $1k | -55.6 % |
| Mar 5, 21 | DASH | $15k | -51.5 % |
| Mar 5, 21 | EQIX | $1k | +8.7 % |
| Mar 5, 21 | EQIX | $1k | +8.7 % |
| Mar 5, 21 | SJM | $15k | +5.4 % |
| Mar 5, 21 | KIM | $15k | +10.7 % |
| Mar 5, 21 | PCRX | $1k | -10.5 % |
| Mar 5, 21 | PCRX | $15k | -10.5 % |
| Mar 5, 21 | PCRX | $1k | -10.5 % |
| Mar 5, 21 | PCRX | $15k | -10.5 % |
| Mar 5, 21 | PCRX | $1k | -10.5 % |
| Mar 5, 21 | PCRX | $15k | -10.5 % |
| Mar 5, 21 | PTON | $15k | -89.1 % |
| Mar 5, 21 | POST | $15k | -18.3 % |
| Mar 5, 21 | TPR | $15k | -36.9 % |
| Mar 5, 21 | YEXT | $1k | -67.9 % |
| Mar 5, 21 | YEXT | $1k | -67.9 % |
| Mar 5, 21 | YEXT | $1k | -67.9 % |
| Mar 5, 21 | YEXT | $1k | -67.9 % |
| Mar 5, 21 | YEXT | $15k | -67.9 % |
| Mar 5, 21 | YEXT | $1k | -67.9 % |
| Mar 5, 21 | YEXT | $15k | -67.9 % |
| Mar 5, 21 | YEXT | $1k | -67.9 % |
⚠️ 55 buys with 12 months of hindsight. Perf vs S&P 500 measured from the disclosure date. Public data (House PTRs), transparency — not advice nor a guarantee.
🔔 Get notified of Tom Malinowski's next trades
Free, unsubscribe anytime. Transparency data, not advice.
Frequently asked questions
Does Tom Malinowski beat the market?
Across 55 disclosed buys (2019-2026) measured from their disclosure date, 18% beat the S&P 500 over 12 months, with a median outperformance of -36.4 %. In other words, Tom Malinowski underperforms the market.
Which stocks does Tom Malinowski buy?
Most-bought tickers: YEXT, PCRX, CDNA, ANIK, EQIX, NEWR. Full detail (dates, amounts, performance) is in the table above.
Is this data reliable?
It comes from official House Periodic Transaction Reports (PTRs), mandatory under the STOCK Act. It's transparency, not advice: past performance doesn't predict the future, and a small number of trades stays statistically weak.